Contact
Please use this form to send email to PR contact of this press release:
VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
TO:
Please use this form to send email to PR contact of this press release:
VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
TO: